Compound details
2-{1-[(1H-imidazol-2-yl)methyl]pyrrolidin-3-yl}-5-(1-methyl-1H-imidazol-5-yl)-1,3,4-oxadiazole
| Compound ID | CDAMM00116 |
|---|---|
| Common name | 2-{1-[(1H-imidazol-2-yl)methyl]pyrrolidin-3-yl}-5-(1-methyl-1H-imidazol-5-yl)-1,3,4-oxadiazole | IUPAC name | 2-[1-(1H-imidazol-2-ylmethyl)pyrrolidin-3-yl]-5-(3-methylimidazol-4-yl)-1,3,4-oxadiazole |
| Molecular formula | C14H17N7O |
| Retention time | 29.98 |
|---|---|
| Adduct | [M+H]+ |
| Actual mz | 300.157 | Theoretical mz | 300.157 |
| Error | 1.89 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 6.2563 |
| Inchi key | BBYLXKMGIXPECX-UHFFFAOYSA-N |
|---|---|
| Smiles | CN1C=NC=C1C2=NN=C(O2)C3CCN(C3)CC4=NC=CN4 |
| Superclass | Organic nitrogen compounds |
| Class | Organonitrogen compounds |
| Uniprot ID | Gene name | Target name | TTD_ID | Prediction source |
|---|
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|